Leadership

We’ve assembled an experienced team with substantial genetic medicines, orphan drug development, and technology development expertise from small and large biopharma companies.
Shehnaaz Suliman, M.D., M.B.A., M.Phil.

President & Chief Executive Officer

Jessica Couch, Ph.D., DABT

Chief Scientific Officer

Vladimir Kharitonov, Ph.D.

Senior Vice President, CMC and Pharmaceutical Sciences

Max Barker, J.D.
Max Barker, J.D.

General Counsel

Shehnaaz Suliman, M.D., M.B.A., M.Phil.

President & Chief Executive Officer

Jessica Couch, Ph.D., DABT

Chief Scientific Officer

Vladimir Kharitonov, Ph.D.

Senior Vice President, CMC & Pharmaceutical Sciences

Max Barker, J.D.
Max Barker, J.D.

General Counsel

Investors